Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

PPBT Purple Biotech Ltd

0,567

-0,034 (-5,66%)

Nach Börsenschluss

Zuletzt aktualisiert: 00:30:47

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Purple Biotech (NASDAQ:PPBT)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Purple Biotech Charts.

Purple Biotech (NASDAQ:PPBT)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Purple Biotech Charts.

News Purple Biotech Ltd

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 4 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 3 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
Samstag 1 Juni 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 21 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Purple Biotech Reports First Quarter 2024 Financial Results
Dienstag 21 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
Donnerstag 25 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024
Donnerstag 28 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
Donnerstag 14 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 6 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Dienstag 5 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results
Dienstag 5 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Purple Biotech Ltd News-Artikel

Gold vs US Dollar

Deutsche Lufthansa

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen